CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Debt Instrument, Convertible, Carrying Amount of Equity Component
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Debt Instrument, Convertible, Carrying Amount of Equity Component of $25.32 million as of 2011-09-24, per its 10-Q filed 2011-11-02.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent · last filed 2011-11-02
- 2011-09-24: Debt Instrument, Convertible, Carrying Amount of Equity Component $25.32M.
| Period end | Debt Instrument, Convertible, Carrying Amount of Equity Component |
|---|---|
| 2011-09-24 | $25.32M 10-Q · filed 2011-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |